Walter G Bradley1, Angeline S Andrew2, Bryan J Traynor3,4, Adriano Chiò5, Tanya H Butt2, Elijah W Stommel2. 1. Department of Neurology, Miller School of Medicine, University of Miami, Miami, Florida, USA. 2. Department of Neurology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA. 3. Neuromuscular Diseases Research Section, Laboratory of Neurogenetics, National Institute of Aging, National Institutes of Health, Bethesda, Maryland, USA. 4. Department of Neurology, Johns Hopkins University, Baltimore, Maryland, USA. 5. "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.
Abstract
BACKGROUND: Amyotrophic lateral sclerosis (ALS), Alzheimer's, and Parkinson's diseases are age-related neurodegenerative diseases. ALS is not a single entity but a syndrome with many different causes. In all 3 diseases, gene mutations account for only 10-15% of cases. Many environmental and lifestyle factors have been implicated as risk factors for ALS, though none have been proven to cause the disease. It is generally believed that ALS results from interactions between environmental risk factors and genetic predisposing factors. The advent of next-generation sequencing and recent advances in research into environmental risk factors offer the opportunity to investigate these interactions. SUMMARY: We propose a hypothesis to explain the syndrome of ALS based on the interaction of many individual environmental risk factors with many individual genetic predisposing factors. We hypothesize that there are many such combinations of individual, specific, genetic, and environmental factors, and that each combination can lead to the development of the syndrome of ALS. We also propose a hypothesis that explains the overlap between the age-related neurodegenerations and their genetic underpinnings. Age and duration of exposure are crucial factors in these age-related neurodegenerative diseases, and we consider how these may relate to gene-environment interactions. KEY MESSAGES: To date, genetic studies and environmental studies have investigated the causes of ALS separately. We argue that this univariate approach will not lead to discoveries of important gene-environment interactions. We propose new research approaches to investigating gene-environment interactions based on these hypotheses.
BACKGROUND: Amyotrophic lateral sclerosis (ALS), Alzheimer's, and Parkinson's diseases are age-related neurodegenerative diseases. ALS is not a single entity but a syndrome with many different causes. In all 3 diseases, gene mutations account for only 10-15% of cases. Many environmental and lifestyle factors have been implicated as risk factors for ALS, though none have been proven to cause the disease. It is generally believed that ALS results from interactions between environmental risk factors and genetic predisposing factors. The advent of next-generation sequencing and recent advances in research into environmental risk factors offer the opportunity to investigate these interactions. SUMMARY: We propose a hypothesis to explain the syndrome of ALS based on the interaction of many individual environmental risk factors with many individual genetic predisposing factors. We hypothesize that there are many such combinations of individual, specific, genetic, and environmental factors, and that each combination can lead to the development of the syndrome of ALS. We also propose a hypothesis that explains the overlap between the age-related neurodegenerations and their genetic underpinnings. Age and duration of exposure are crucial factors in these age-related neurodegenerative diseases, and we consider how these may relate to gene-environment interactions. KEY MESSAGES: To date, genetic studies and environmental studies have investigated the causes of ALS separately. We argue that this univariate approach will not lead to discoveries of important gene-environment interactions. We propose new research approaches to investigating gene-environment interactions based on these hypotheses.
Authors: Badri N Vardarajan; Kelley M Faber; Thomas D Bird; David A Bennett; Roger Rosenberg; Bradley F Boeve; Neill R Graff-Radford; Alison M Goate; Martin Farlow; Robert A Sweet; Rafael Lantigua; Martin Z Medrano; Ruth Ottman; Daniel J Schaid; Tatiana M Foroud; Richard Mayeux Journal: JAMA Neurol Date: 2014-03 Impact factor: 18.302
Authors: Angeline S Andrew; Erik P Pioro; Meifang Li; Xun Shi; Jiang Gui; Elijah W Stommel; Tanya H Butt; Daniel Peipert; Patricia Henegan; Maeve Tischbein; Pamela Cazzolli; John Novak; Adam Quick; K Doug Pugar; Komal Sawlani; Bashar Katirji; Todd A Hayes; D Kevin Horton; Paul Mehta; Walter G Bradley Journal: Neuroepidemiology Date: 2021-04-26 Impact factor: 3.282
Authors: Matt Keon; Benjamin Musrie; Marcel Dinger; Samuel E Brennan; Jerran Santos; Nitin K Saksena Journal: Front Neurol Date: 2021-03-29 Impact factor: 4.003